3 articles, transcripts, and reports
Allergan plc (NYSE: AGN), which is all set to be acquired by rival drugmaker AbbVie (ABBV), reported a 21% increase in fourth-quarter adjusted earnings that…
Allergan plc (NYSE: AGN) reported a wider loss in the third quarter of 2019 due to the divestitures, products that lost or are at risk…
After securing shareholders’ approval for the takeover deal with AbbVie (ABBV), Allergan (NYSE: AGN) will be publishing its third-quarter results on November 5 at 7:00…
